Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands

Pediatric Diabetes

Volumn 17, Issue 1, 2016, Pages 44-52

  Fazeli Farsani, Soulmaz ^a   Souverein, Patrick C ^a   van der Vorst, Marja M J ^b   Knibbe, Catherijne A J ^b,c   Herings, Ron M C ^d   de Boer, Anthonius ^a   Mantel Teeuwisse, Aukje K ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

Author keywords

Adolescents; Children; Incidence rate; Prevalence rate; Time trends; Type 1 diabetes

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; TREND STUDY; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; HEALTH SURVEY; INFANT; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84953289409     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12232     Document Type: Article

References (43)

1. International Diabetes Federation. IDF Diabetes Atlas. 6th edn. Brussels, Belgium: International Diabetes Federation, 2013.
2. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009: 373: 2027-2033.
3. Patterson CC, Gyurus E, Rosenbauer J et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012: 55: 2142-2147.
4. Patterson C, Guariguata L, Dahlquist G, Soltesz G, Ogle G, Silink M. Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 2014: 103: 161-175.
5. Rawshani A, Landin-Olsson M, Svensson AM et al. The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia 2014: 57: 1375-1381.
6. Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008: 371: 1777-1782.
7. Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA 2013: 310: 427-428.
8. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006: 23: 857-866.
9. Berhan Y, Waernbaum I, Lind T, Mollsten A, Dahlquist G, Swedish Childhood Diabetes Study Group. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011: 60: 577-581.
10. Cinek O, Kulich M, Sumnik Z. The incidence of type 1 diabetes in young Czech children stopped rising. Pediatr Diabetes 2012: 13: 559-563.
11. Skrivarhaug T, Stene LC, Drivvoll AK, Strom H, Joner G, Norwegian Childhood Diabetes Study Group. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 2014: 57: 57-62.
12. Knip M. Descriptive epidemiology of type 1 diabetes - is it still in? Diabetologia 2012: 55: 1227-1230.
13. Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005: 54 (Suppl. 2): S125-S136.
14. Vaandrager GJ, Bruining GJ, Veenhof FJ, Drayer NM. Incidence of childhood diabetes in the Netherlands: a decrease from north to south over north-western Europe? Diabetologia 1984: 27: 203-206.
15. Ruwaard D, Hirasing RA, Reeser HM et al. Increasing incidence of type I diabetes in the Netherlands. The second nationwide study among children under 20 years of age. Diabetes Care 1994: 17: 599-601.
16. Van Wouwe JP, Verkerk PH, Mattiazzo GF, El Mokadem N, Hirasing RA. Variation by ethnicity in incidence of diabetes type 1 and clinical condition at onset in the Netherlands. Eur J Pediatr 2002: 161: 559-560.
17. Herings RM, de Boer A, Stricker BH, Bakker A, Sturmans F. A rapid method to estimate the incidence rate and prevalence of insulin-dependent diabetes mellitus in children 0-19 years of age. Pharm World Sci 1995: 17: 17-19.
18. PHARMO Institute for Drug Outcome Research. Available at http://pharmo.nl. Accessed July 2014.
19. Overbeek JA, Penning-van Beest FJ, Heintjes EM et al. Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands. BMC Res Notes 2011: 4: 402.
20. Houweling LM, Bezemer ID, Penning-van Beest FJ, Meijer WM, van Lingen RA, Herings RM. First year of life medication use and hospital admission rates: premature compared with term infants. J Pediatr 2013: 163: 61.e1-66.e1.
21. Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 2008: 33: 17-23.
22. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2014. Available at http://www.whocc.no/atc_ddd_index/. Accessed July 2014.
23. Centraal Bureau voor de Statistiek. Available at http://www.cbs.nl/nl-NL/menu/home/default.htm. Accessed July 2014
24. Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, de Boer A. Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 2001: 54: 1181-1186.
25. Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Br J Clin Pharmacol 2009: 67: 242-249.
26. Fazeli Farsani S, Souverein PC, van der Vorst MM, Mantel-Teeuwisse AK, Knibbe CA, de Boer A. Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study. PLoS One 2014: 9: e87408.
27. Fazeli Farsani S, Souverein PC, van der Vorst MM, Knibbe CA, de Boer A, Mantel-Teeuwisse AK. Anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents: a population-based cohort study. Antimicrob Agents Chemother 2014.
28. Regeling Geneesmiddelenwet. Available at: http://wetten.overheid.nl/BWBR0022160/geldigheidsdatum_25-06-2014#Hoofdstuk6. Accessed July 2014.
29. Abdelmoneim AS, Eurich DT, Gamble JM, Simpson SH. Use patterns of antidiabetic regimens by patients with type 2 diabetes. Can J Diabetes 2013 Dec: 37: 394-400.
30. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000: 19: 335-351.
31. Joinpoint Regression Program, Version 4.1.0. Statistical Methodology and Applications Branch, Surveillance Research Program. National Cancer Institute, Bethesda, MD, USA, April 2014.
32. TRIGR Study Group. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 2007: 8: 117-137.
33. TRIGR Study Group, Akerblom HK, Krischer J et al. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia 2011: 54: 627-633.
34. Fazeli Farsani S, van der Aa MP, van der Vorst MM, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia 2013: 56: 1471-1488.
35. Neu A, Feldhahn L, Ehehalt S, Hub R, Ranke MB, DIARY group Baden-Wurttemberg. Type 2 diabetes mellitus in children and adolescents is still a rare disease in Germany: a population-based assessment of the prevalence of type 2 diabetes and MODY in patients aged 0-20 years. Pediatr Diabetes 2009: 10: 468-473.
36. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010: 363: 2339-2350.
37. Kanakatti Shankar R, Pihoker C, Dolan LM et al. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes 2013: 14: 174-180.
38. Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 2011: 343: d6044.
39. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG, British Society for Paediatric Endocrinology and Diabetes Clinical Trials Group. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004: 89: 526-529.
40. Martikainen MH, Ronnemaa T, Majamaa K. Prevalence of mitochondrial diabetes in southwestern Finland: a molecular epidemiological study. Acta Diabetol 2013: 50: 737-741.
41. Brufani C, Fintini D, Nobili V, Patera PI, Cappa M, Brufani M. Use of metformin in pediatric age. Pediatr Diabetes 2011: 12: 580-588.
42. Ludvigsson J. The latest pharmacotherapy options for type 1 diabetes. Expert Opin Pharmacother 2014: 15: 37-49.
43. Nadeau KJ, Chow K, Alam S et al. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study. Pediatr Diabetes 2014.